Abbott Laboratories buy Citigroup Inc.
Start price
25.01.24
/
50%
€102.48
Target price
25.01.25
€116.25
Performance (%)
0.50%
Price
30.08.24
€102.48
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ for Abbott Laboratories is nearly unchanged. Dividends of €0.52 are taken into consideration when calculating the performance. This prediction currently runs until 25.01.25. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Abbott Laboratories | 1.788% | 1.788% |
iShares Core DAX® | 1.560% | 2.566% |
iShares Nasdaq 100 | 0.517% | 1.894% |
iShares Nikkei 225® | 1.730% | 5.631% |
iShares S&P 500 | 1.482% | 1.594% |
Comments by Citigroup_Inc_ for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Citigroup Inc. from $123.00 to $126.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€100.50
22.08.24
22.08.24
€114.22
22.08.25
22.08.25
1.97%
30.08.24
30.08.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€96.77
22.05.24
22.05.24
€109.79
22.05.25
22.05.25
5.90%
30.08.24
30.08.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€103.10
03.04.24
03.04.24
€118.21
03.04.25
03.04.25
-0.10%
30.08.24
30.08.24